With commercial insurance: Amgen Commercial Co-Pay Program for Tepezza — as little as $0. With Medicare: the Tepezza card can’t be used. The Assistance Fund – Thyroid Eye Disease (TED) is open as of September 28, 2026.
See what this patient owes after assistance →
5 assistance programs for Tepezza patients · 2 open today
Manufacturer savings, charitable foundations, and patient assistance programs.
Select the patient's insurance and diagnosis to see which programs may apply.
Current status · Award amounts · Eligibility · Direct application links September 29, 2026
Checked September 28, 2026 · Source 1 ↗ · Source 2 ↗
Checked September 28, 2026 · Source ↗
Tepezza’s card can’t be used with Medicare. These funds may help. They open and close with donations, so call before telling a Tepezza patient no.
Checked September 28, 2026 · Source 1 ↗ · Source 2 ↗
Tepezza · Thyroid eye disease · Commercial insurance
Eligible patients may pay $0
Example · Tepezza · 1600 mg · 160 units + 40 JW · commercial plan · deductible met · 20% coinsurance · allowed amounts at the Medicare reference rate
| Without assistance | With Amgen Commercial Co-Pay Program (via Amgen By Your Side) for Tepezza | |
|---|---|---|
| Drug responsibility | $15,265.08 | $0.00 |
| Administration (96413) | $26.65 | $0.00 |
| Patient owes | $15,291.73 | $0.00 |
Estimated patient savings: $15,291.73
CareCost calculates the drug and administration lines using the patient’s payer rate and benefits; this example uses the Medicare rate as a reference.
Checked, and not available for this drug today
Free Amgen SafetyNet Foundation for eligible patients
Change the diagnosis to see only the programs that apply to your patient.
No biosimilar or same-class alternative with its own HCPCS code is on file for Tepezza; the programs above are the only ones that apply.
| Task | ✓ |
|---|---|
| Find programs for the diagnosis | ✓ |
| See whether each program is open | ✓ |
| See maximum award | ✓ |
| Review key eligibility requirements | ✓ |
| Open the official application | ✓ |
| Calculate cost before assistance | ✓ |
| Apply the program benefit | ✓ |
| Calculate what the patient still owes | ✓ |
Commercial insurance — the Amgen Commercial Co-Pay Program (via Amgen By Your Side) for Tepezza Program (Amgen By Your Side) brings eligible patients' cost to $0 for both the Tepezza drug charge and the infusion administration line, one of the few manufacturer cards that covers the second line at all. The annual maximum is listed only as “See program”; call Amgen By Your Side at 833-469-8331 for the current amount. The program is commercial plan only, excluding Medicare, Medicaid, TRICARE, VA and other government insurance. View current program ↑
Medicare — the Amgen Commercial Co-Pay Program (via Amgen By Your Side) for Tepezza Program is commercial plan only and does not apply, and Amgen runs no free-drug program for Tepezza. Of the three foundation funds, The Assistance Fund's Thyroid Eye Disease (TED) fund accepts commercial, Medicare and Medicaid patients, with no stated maximum; check each fund's current status on the funds list. Good Days' Thyroid Eye Disease fund is paused while it seeks donations and keeps no waitlist. TotalAssist's Thyroid Eye Disease fund is up to $9,000 a year; check each fund's current status on the funds list. A Medigap plan can pick up the Part B coinsurance instead; see the cost page for the Plan K and Plan L figures.
Good Days' Thyroid Eye Disease fund is not currently accepting new enrollments; the foundation's own status is “seeking funds,” not open, as of the July 31, 2026 check. The Assistance Fund's TED fund is the only foundation grant open for Tepezza today; confirm availability directly at 855-928-1145 before counting on either one, since foundation funds can close without notice.
How the lines work — Tepezza is billed per 10 mg under J3241 for thyroid eye disease, coded to H05.24, a category code; payers recognize the more specific H05.241–H05.249 codes by eye, and the funds above match on the J-code and the thyroid eye disease diagnosis. The example on this page is the 20 mg/kg maintenance dose: for an 80 kg patient that is 1,600 mg, billed as 160 units of J3241 from four 500 mg vials, with the 400 mg remainder reported separately as 40 units on a JW line. The only vial size is 500 mg, so most weights leave some drug discarded this way. The infusion itself is a separate line, 96413, run at least 60 minutes if the first two infusions in the course were well tolerated and at least 90 minutes if not. Each line carries its own patient share under commercial coinsurance, and the Amgen Commercial Co-Pay Program (via Amgen By Your Side) for Tepezza Program's terms cover both; the example estimate above applies it to the drug line only. Tepezza has no biosimilar and no same-class alternative billed under its own J-code, so this is the only manufacturer program to check.
Yes. The Amgen Commercial Co-Pay Program (via Amgen By Your Side) for Tepezza Program (Amgen By Your Side) brings eligible commercially insured patients' cost to $0, for both the drug and its infusion administration. The annual maximum is listed only as “See program”; call Amgen By Your Side at 833-469-8331 for the current amount. Apply on Amgen By Your Side ↗ Calculate cost with the program →
Yes. Unlike most manufacturer copay cards, its terms cover both the Tepezza drug charge and the infusion administration line; it does not cover a separate office visit fee. The program is commercial plan only, excluding Medicare, Medicaid, TRICARE, VA and other government insurance. View current program ↑
Not from the Amgen Commercial Co-Pay Program (via Amgen By Your Side) for Tepezza Program for J3241, which is commercial plan only, and Amgen runs no free-drug program for Tepezza. The Assistance Fund's Thyroid Eye Disease (TED) fund accepts commercial, Medicare and Medicaid patients, with no stated maximum; Good Days' Thyroid Eye Disease fund keeps no waitlist when it is not enrolling; TotalAssist's Thyroid Eye Disease fund is up to $9,000 a year; check each fund's current status on the funds list. A Medigap plan can cover the Part B coinsurance instead; see the cost page. Check current Medicare options ↑
No. Amgen runs no free-drug program for Tepezza, and Tepezza is not on the Amgen Safety Net Foundation's product list (checked September 27, 2026). Amgen By Your Side (833-469-8331) refers uninsured patients to independent foundations. Contact Amgen By Your Side ↗
The Assistance Fund's Thyroid Eye Disease (TED) fund, with no stated maximum, is the one to check first; check each fund's current status on the funds list. Good Days also runs a Thyroid Eye Disease fund, but it is paused while it seeks donations and keeps no waitlist. TotalAssist's Thyroid Eye Disease fund is up to $9,000 a year; check each fund's current status on the funds list. Check today's status ↑
A denial does not change the Tepezza assistance programs available; a commercially insured patient can still use the Amgen Commercial Co-Pay Program (via Amgen By Your Side) for Tepezza Program once coverage is resolved. Review the plan's prior authorization requirements on the coverage page.
Data current: programs verified Sep 29, 2026
Amgen Commercial Co-Pay Program (via Amgen By Your Side) for Tepezza Program (Amgen By Your Side) · The Assistance Fund's, Good Days' and TotalAssist's Thyroid Eye Disease funds. Every program links directly to its official source or application page.
Last program check: .
Reviewed September 21, 2026 by Erin Rose, CareCost Estimate founder. Methodology →
CareCost